Annual EBITDA:
-$100.97M+$702.00K(+0.69%)Summary
- As of today, TERN annual EBITDA is -$100.97 million, with the most recent change of +$702.00 thousand (+0.69%) on December 31, 2024.
- During the last 3 years, TERN annual EBITDA has fallen by -$51.63 million (-104.62%).
- TERN annual EBITDA is now -449.08% below its all-time high of -$18.39 million, reached on December 31, 2018.
Performance
TERN EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Quarterly EBITDA:
-$27.61M-$330.00K(-1.21%)Summary
- As of today, TERN quarterly EBITDA is -$27.61 million, with the most recent change of -$330.00 thousand (-1.21%) on September 30, 2025.
- Over the past year, TERN quarterly EBITDA has dropped by -$2.87 million (-11.61%).
- TERN quarterly EBITDA is now -218.69% below its all-time high of -$8.66 million, reached on December 31, 2020.
Performance
TERN Quarterly EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM EBITDA:
-$107.87M-$2.87M(-2.74%)Summary
- As of today, TERN TTM EBITDA is -$107.87 million, with the most recent change of -$2.87 million (-2.74%) on September 30, 2025.
- Over the past year, TERN TTM EBITDA has dropped by -$8.79 million (-8.88%).
- TERN TTM EBITDA is now -992.83% below its all-time high of -$9.87 million, reached on December 31, 2019.
Performance
TERN TTM EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
EBITDA Formula
EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization
TERN EBITDA Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1Y1 Year | +0.7% | -11.6% | -8.9% |
| 3Y3 Years | -104.6% | -62.0% | -85.5% |
| 5Y5 Years | -44.3% | -218.7% | -285.3% |
TERN EBITDA Highs & Lows
| PeriodPeriod | Annual vs HighAnnual vs High | Annual vs LowAnnual vs Low | Quarter. vs HighQuarter. vs High | Quarter. vs LowQuarter. vs Low | TTM vs HighTTM vs High | TTM vs LowTTM vs Low | |
|---|---|---|---|---|---|---|---|
| 3Y | 3-Year | -104.6% | +0.7% | -68.9% | +16.3% | -85.5% | at low |
| 5Y | 5-Year | -175.7% | +0.7% | -218.7% | +16.3% | -285.3% | at low |
| All-Time | All-Time | -449.1% | +0.7% | -218.7% | +16.3% | -992.8% | at low |
TERN EBITDA History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2025 | - | -$27.61M(-1.2%) | -$107.87M(-2.7%) |
| Jun 2025 | - | -$27.27M(-0.1%) | -$105.00M(-1.9%) |
| Mar 2025 | - | -$27.26M(-5.9%) | -$103.02M(-2.0%) |
| Dec 2024 | -$100.97M(+0.7%) | -$25.73M(-4.1%) | -$100.97M(-1.9%) |
| Sep 2024 | - | -$24.73M(+2.2%) | -$99.08M(+7.7%) |
| Jun 2024 | - | -$25.30M(-0.3%) | -$107.31M(-4.2%) |
| Mar 2024 | - | -$25.21M(-5.8%) | -$102.95M(-1.3%) |
| Dec 2023 | -$101.68M(-66.7%) | -$23.84M(+27.7%) | -$101.68M(-8.0%) |
| Sep 2023 | - | -$32.96M(-57.4%) | -$94.18M(-20.3%) |
| Jun 2023 | - | -$20.94M(+12.5%) | -$78.26M(-10.0%) |
| Mar 2023 | - | -$23.93M(-46.5%) | -$71.13M(-17.1%) |
| Dec 2022 | -$61.00M | -$16.34M(+4.1%) | -$60.74M(-4.4%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2022 | - | -$17.04M(-23.3%) | -$58.17M(-10.0%) |
| Jun 2022 | - | -$13.81M(-2.0%) | -$52.89M(-6.3%) |
| Mar 2022 | - | -$13.55M(+1.6%) | -$49.77M(-0.9%) |
| Dec 2021 | -$49.35M(-34.7%) | -$13.76M(-17.0%) | -$49.35M(-11.5%) |
| Sep 2021 | - | -$11.76M(-9.9%) | -$44.25M(-36.2%) |
| Jun 2021 | - | -$10.70M(+18.5%) | -$32.48M(-2.2%) |
| Mar 2021 | - | -$13.12M(-51.5%) | -$31.78M(-13.5%) |
| Dec 2020 | -$36.63M(+47.7%) | -$8.66M(+13.4%) | -$28.00M(+4.1%) |
| Jun 2020 | - | -$10.00M(-7.1%) | -$29.20M(-52.1%) |
| Mar 2020 | - | -$9.34M(+5.4%) | -$19.21M(-94.6%) |
| Dec 2019 | -$70.00M(-280.7%) | -$9.87M | -$9.87M |
| Dec 2018 | -$18.39M | - | - |
FAQ
- What is Terns Pharmaceuticals, Inc. annual EBITDA?
- What is the all-time high annual EBITDA for Terns Pharmaceuticals, Inc.?
- What is Terns Pharmaceuticals, Inc. annual EBITDA year-on-year change?
- What is Terns Pharmaceuticals, Inc. quarterly EBITDA?
- What is the all-time high quarterly EBITDA for Terns Pharmaceuticals, Inc.?
- What is Terns Pharmaceuticals, Inc. quarterly EBITDA year-on-year change?
- What is Terns Pharmaceuticals, Inc. TTM EBITDA?
- What is the all-time high TTM EBITDA for Terns Pharmaceuticals, Inc.?
- What is Terns Pharmaceuticals, Inc. TTM EBITDA year-on-year change?
What is Terns Pharmaceuticals, Inc. annual EBITDA?
The current annual EBITDA of TERN is -$100.97M
What is the all-time high annual EBITDA for Terns Pharmaceuticals, Inc.?
Terns Pharmaceuticals, Inc. all-time high annual EBITDA is -$18.39M
What is Terns Pharmaceuticals, Inc. annual EBITDA year-on-year change?
Over the past year, TERN annual EBITDA has changed by +$702.00K (+0.69%)
What is Terns Pharmaceuticals, Inc. quarterly EBITDA?
The current quarterly EBITDA of TERN is -$27.61M
What is the all-time high quarterly EBITDA for Terns Pharmaceuticals, Inc.?
Terns Pharmaceuticals, Inc. all-time high quarterly EBITDA is -$8.66M
What is Terns Pharmaceuticals, Inc. quarterly EBITDA year-on-year change?
Over the past year, TERN quarterly EBITDA has changed by -$2.87M (-11.61%)
What is Terns Pharmaceuticals, Inc. TTM EBITDA?
The current TTM EBITDA of TERN is -$107.87M
What is the all-time high TTM EBITDA for Terns Pharmaceuticals, Inc.?
Terns Pharmaceuticals, Inc. all-time high TTM EBITDA is -$9.87M
What is Terns Pharmaceuticals, Inc. TTM EBITDA year-on-year change?
Over the past year, TERN TTM EBITDA has changed by -$8.79M (-8.88%)